Annual Shareholders Equity
$3.60 M
+$860.70 K+31.39%
December 31, 2023
Summary
- As of February 7, 2025, ENTO annual stockholders equity is $3.60 million, with the most recent change of +$860.70 thousand (+31.39%) on December 31, 2023.
- During the last 3 years, ENTO annual shareholders equity has risen by +$6.24 million (+236.44%).
- ENTO annual shareholders equity is now -21.97% below its all-time high of $4.62 million, reached on December 1, 2019.
Performance
ENTO Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Shareholders Equity
$70.05 M
-$751.60 K-1.06%
September 1, 2024
Summary
- As of February 7, 2025, ENTO quarterly stockholders equity is $70.05 million, with the most recent change of -$751.60 thousand (-1.06%) on September 1, 2024.
- Over the past year, ENTO quarterly shareholders equity has increased by +$66.45 million (+1844.27%).
- ENTO quarterly shareholders equity is now -10.04% below its all-time high of $77.86 million, reached on March 31, 2024.
Performance
ENTO Quarterly Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Shareholders Equity Formula
Shareholders Equity = Total Assets − Total Liabilities
ENTO Shareholders Equity Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +31.4% | +1844.3% |
| 3 y3 years | +236.4% | +2482.4% |
| 5 y5 years | -19.5% | +2087.8% |
ENTO Shareholders Equity Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +146.1% | -10.0% | +593.7% |
| 5 y | 5-year | -22.0% | +146.1% | -10.0% | +593.7% |
| alltime | all time | -22.0% | +146.1% | -10.0% | +593.7% |
Entero Therapeutics Shareholders Equity History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $70.05 M(-1.1%) |
| Jun 2024 | - | $70.80 M(-9.1%) |
| Mar 2024 | - | $77.86 M(+2061.1%) |
| Dec 2023 | $3.60 M(+31.4%) | $3.60 M(+9.9%) |
| Sep 2023 | - | $3.28 M(+271.7%) |
| Jun 2023 | - | $882.00 K(-67.5%) |
| Mar 2023 | - | $2.71 M(-1.1%) |
| Dec 2022 | $2.74 M(-135.1%) | - |
| Dec 2022 | - | $2.74 M(-220.3%) |
| Sep 2022 | - | -$2.28 M(-83.9%) |
| Jun 2022 | - | -$14.19 M(+53.6%) |
| Mar 2022 | - | -$9.24 M(+18.1%) |
| Dec 2021 | -$7.82 M(+196.2%) | -$7.82 M(+12.2%) |
| Sep 2021 | - | -$6.97 M(-199.0%) |
| Jun 2021 | - | $7.04 M(-51.1%) |
| Mar 2021 | - | $14.40 M(-645.4%) |
| Dec 2020 | -$2.64 M | -$2.64 M(-118.8%) |
| Sep 2020 | - | $14.07 M(-1863.9%) |
| Jun 2020 | - | -$797.40 K(-126.2%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2020 | - | $3.04 M(-34.1%) |
| Dec 2019 | $4.62 M(+3.2%) | $4.62 M(+44.2%) |
| Sep 2019 | - | $3.20 M(+8.6%) |
| Jun 2019 | - | $2.95 M(+8.7%) |
| Mar 2019 | - | $2.71 M(-39.4%) |
| Dec 2018 | $4.47 M(+169.4%) | $4.47 M(-19.1%) |
| Sep 2018 | - | $5.53 M(-27.5%) |
| Jun 2018 | - | $7.63 M(+594.4%) |
| Mar 2018 | - | $1.10 M(-33.8%) |
| Dec 2017 | $1.66 M(-48.3%) | $1.66 M(-40.6%) |
| Sep 2017 | - | $2.80 M(-39.8%) |
| Jun 2017 | - | $4.64 M(+215.7%) |
| Mar 2017 | - | $1.47 M(-54.2%) |
| Dec 2016 | $3.21 M(-188.5%) | $3.21 M(-126.0%) |
| Sep 2016 | - | -$12.37 M(+33.9%) |
| Jun 2016 | - | -$9.23 M(+70.4%) |
| Mar 2016 | - | -$5.42 M(+49.3%) |
| Dec 2015 | -$3.63 M(-237.2%) | -$3.63 M |
| Dec 2014 | $2.64 M | - |
FAQ
- What is Entero Therapeutics annual stockholders equity?
- What is the all time high annual shareholders equity for Entero Therapeutics?
- What is Entero Therapeutics annual shareholders equity year-on-year change?
- What is Entero Therapeutics quarterly stockholders equity?
- What is the all time high quarterly shareholders equity for Entero Therapeutics?
- What is Entero Therapeutics quarterly shareholders equity year-on-year change?
What is Entero Therapeutics annual stockholders equity?
The current annual shareholders equity of ENTO is $3.60 M
What is the all time high annual shareholders equity for Entero Therapeutics?
Entero Therapeutics all-time high annual stockholders equity is $4.62 M
What is Entero Therapeutics annual shareholders equity year-on-year change?
Over the past year, ENTO annual stockholders equity has changed by +$860.70 K (+31.39%)
What is Entero Therapeutics quarterly stockholders equity?
The current quarterly shareholders equity of ENTO is $70.05 M
What is the all time high quarterly shareholders equity for Entero Therapeutics?
Entero Therapeutics all-time high quarterly stockholders equity is $77.86 M
What is Entero Therapeutics quarterly shareholders equity year-on-year change?
Over the past year, ENTO quarterly stockholders equity has changed by +$66.45 M (+1844.27%)